FDA’s Fall Regulatory Agenda Adds Several New Proposed and Final Rules Post author:PacConAdmin Post published:December 19, 2021 Post category:Drug Industry Daily The FDA’s fall 2021 regulatory agenda includes several new proposed and final rules. Source: Drug Industry Daily You Might Also Like U.S. Appellate Judge Sides With Broad Institute in CRISPR Patent Case May 1, 2018 CBER Director Touts PDUFA Progress, Therapeutic Firsts in Fiscal 2017 January 5, 2018 Senators Re-Introduce Bill to Close REMS Patent Loophole March 1, 2023